Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

221 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Engraftment and Measurable Residual Disease Monitoring after Hematopoietic Stem Cell Transplantation: Comparison of Two Chimerism Test Strategies, Next-Generation Sequencing versus a Combination of Short-Tandem Repeats and Quantitative PCR.
Zhang A, Macecevic S, Thomas D, Allen J, Mandley S, Kawczak P, Jurcago R, Tyler J, Casey H, Bosler D, Sobecks R, Hamilton B, Sauter C, Mineishi S, Claxton D, Shike H. Zhang A, et al. Among authors: claxton d. J Mol Diagn. 2024 Apr;26(4):233-244. doi: 10.1016/j.jmoldx.2024.01.007. Epub 2024 Feb 1. J Mol Diagn. 2024. PMID: 38307253
Assessment of chimerism by next generation sequencing: A comparison to STR/qPCR methods.
Brow D, Shike H, Kendrick J, Pettersson L, Mineishi S, Claxton DF, Wirk B, Cioccio J, Greiner RJ, Viswanatha D, Kharfan-Dabaja MA, Li Z, Tyler J, Elrefaei M. Brow D, et al. Among authors: claxton df. Hum Immunol. 2024 May;85(3):110794. doi: 10.1016/j.humimm.2024.110794. Epub 2024 Mar 28. Hum Immunol. 2024. PMID: 38553384
Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation.
Zulch E, Inoue Y, Cioccio J, Rakszawski K, Songdej N, Nickolich M, Zheng H, Naik S, Rybka W, Ehmann C, Sivik J, Mierski J, Silar B, Vajdic C, Greiner R, Brown V, Hohl R, Claxton D, Shike H, Paules CI, Mineishi S, Minagawa K. Zulch E, et al. Among authors: claxton d. Leuk Res. 2024 Aug;143:107530. doi: 10.1016/j.leukres.2024.107530. Epub 2024 Jun 3. Leuk Res. 2024. PMID: 38852515
Recurrent disease after a matched sibling hematopoietic transplant in an aplastic anemia patient with a disease risk allele, HLA-B*40:02.
Khosla A, Inoue Y, Cioccio J, Rakszawski K, Songdej N, Nickolich M, Zheng H, Naik S, Ehmann C, Claxton D, Rybka W, Sivik J, Mierski J, Silar B, Vajdic C, Hohl R, Shike H, Mineishi S, Minagawa K. Khosla A, et al. Among authors: claxton d. Blood Transfus. 2024 Nov;22(6):525-528. doi: 10.2450/BloodTransfus.674. Epub 2024 Aug 26. Blood Transfus. 2024. PMID: 39447189 Free PMC article. No abstract available.
Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells.
Qian F, Nettleford SK, Zhou J, Arner BE, Hall MA, Sharma A, Annageldiyev C, Rossi RM, Tukaramrao DB, Sarkar D, Hegde S, Gandhi UH, Finch ER, Goodfield L, Quickel MD, Claxton DF, Paulson RF, Prabhu KS. Qian F, et al. Among authors: claxton df. Cell Rep. 2023 Jul 25;42(7):112794. doi: 10.1016/j.celrep.2023.112794. Epub 2023 Jul 18. Cell Rep. 2023. PMID: 37459233 Free PMC article.
Acute myeloid leukemia stratifies as two clinically relevant sphingolipidomic subtypes.
Paudel BB, Tan SF, Fox TE, Ung J, Shaw J, Dunton W, Lee I, Sharma A, Viny AD, Barth BM, Tallman MS, Cabot M, Garrett-Bakelman FE, Levine RL, Kester M, Claxton D, Feith DJ, Janes KA, Loughran TP Jr. Paudel BB, et al. Among authors: claxton d. bioRxiv [Preprint]. 2023 Apr 17:2023.04.13.536805. doi: 10.1101/2023.04.13.536805. bioRxiv. 2023. Update in: Blood Adv. 2024 Mar 12;8(5):1137-1142. doi: 10.1182/bloodadvances.2023010535 PMID: 37131653 Free PMC article. Updated. Preprint.
Sensitivity and Specificity of Chimerism Tests in Predicting Leukemia Relapse Using Increasing Mixed Chimerism.
Zhang R, Shang Y, Cioccio J, Rakszawski K, Nickolich M, Ehmann C, Inoue Y, Naik S, Rybka W, Zheng H, Mierski J, Silar B, Liao J, Greiner R, Brown V, Claxton D, Ning J, Zhou S, Mineishi S, Minagawa K, Shike H. Zhang R, et al. Among authors: claxton d. J Mol Diagn. 2024 Dec;26(12):1159-1170. doi: 10.1016/j.jmoldx.2024.09.003. J Mol Diagn. 2024. PMID: 39603755
221 results